Rigel Pharmaceuticals, Inc. RIGL
RIGL
Rigel Pharmaceuticals, Inc. GOSS
Gossamer Bio, Inc. KALV
KalVista Pharmaceuticals, Inc. PRTA
Prothena Corporation plc VTYX
Ventyx Biosciences, Inc. FDMT
4D Molecular Therapeutics, Inc. AKBA
Akebia Therapeutics, Inc. CRVS
Corvus Pharmaceuticals, Inc. OLMA
Olema Pharmaceuticals, Inc. BCYC
Bicycle Therapeutics plc
Rigel Pharmaceuticals, Inc. GOSS
Gossamer Bio, Inc. KALV
KalVista Pharmaceuticals, Inc. PRTA
Prothena Corporation plc VTYX
Ventyx Biosciences, Inc. FDMT
4D Molecular Therapeutics, Inc. AKBA
Akebia Therapeutics, Inc. CRVS
Corvus Pharmaceuticals, Inc. OLMA
Olema Pharmaceuticals, Inc. BCYC
Bicycle Therapeutics plc
Performance
| Periode | RIGL | GOSS | KALV | PRTA | VTYX | FDMT | AKBA | CRVS | OLMA | BCYC |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 98.77 % | 181.40 % | 25.56 % | 102.70 % | 248.98 % | 150.69 % | -53.36 % | 86.89 % | 673.77 % | -15.18 % |
| YTD | 143.19 % | 274.23 % | 90.74 % | -24.38 % | 297.90 % | 87.48 % | -12.37 % | 54.88 % | 466.79 % | -48.26 % |
| 1Y | 115.67 % | 409.40 % | 85.92 % | -26.94 % | 226.25 % | 58.40 % | -13.28 % | 3.70 % | 275.39 % | -64.77 % |
| 3Y | 326.75 % | 66.51 % | 185.95 % | -83.20 % | -70.21 % | -57.07 % | 346.38 % | 741.00 % | 1 226.47 % | -75.62 % |
| 5Y | 32.04 % | -64.06 % | -10.25 % | -7.45 % | -59.49 % | -73.01 % | -41.99 % | 111.31 % | -27.06 % | -61.70 % |
| 10Y | 33.29 % | -79.77 % | -61.43 % | -84.48 % | -59.49 % | -73.01 % | -82.92 % | -40.98 % | -35.57 % | -38.08 % |
| Depuis le début | -93.42 % | -79.77 % | -78.29 % | 43.58 % | -59.49 % | -73.01 % | -93.76 % | -40.98 % | -35.57 % | -38.08 % |